Nonalcoholic fatty liver disease and type 2 diabetes: a burgeoning problem with unclear solutions

doi:10.21037/hbsn.2019.11.28

Editorial

. 2020 Aug;9(4):514-517.

doi: 10.21037/hbsn.2019.11.28.

Nonalcoholic fatty liver disease and type 2 diabetes: a burgeoning problem with unclear solutions

Mariana Lazo¹, Jeanne M Clark^{1

2}

Affiliations

¹ Division of General Internal Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
² Division of Gastroenterology & Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

PMID: 32832507
PMCID: PMC7423546
DOI: 10.21037/hbsn.2019.11.28

Editorial

Nonalcoholic fatty liver disease and type 2 diabetes: a burgeoning problem with unclear solutions

Mariana Lazo et al. Hepatobiliary Surg Nutr. 2020 Aug.

. 2020 Aug;9(4):514-517.

doi: 10.21037/hbsn.2019.11.28.

Authors

Mariana Lazo¹, Jeanne M Clark^{1

2}

Affiliations

¹ Division of General Internal Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
² Division of Gastroenterology & Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

PMID: 32832507
PMCID: PMC7423546
DOI: 10.21037/hbsn.2019.11.28

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/hbsn.2019.11.28). The authors have no conflicts of interest to declare.

Comment on

The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, Qiu Y, Burns L, Afendy A, Nader F. Younossi ZM, et al. J Hepatol. 2019 Oct;71(4):793-801. doi: 10.1016/j.jhep.2019.06.021. Epub 2019 Jul 4. J Hepatol. 2019. PMID: 31279902

Cited by

Developmental modeling of hepatogenesis using obese iPSCs-hepatocyte differentiation uncovers pathological features.
Varghese DS, Alawathugoda TT, Sheikh MA, Challagandla AK, Emerald BS, Ansari SA. Varghese DS, et al. Cell Death Dis. 2022 Aug 1;13(8):670. doi: 10.1038/s41419-022-05125-9. Cell Death Dis. 2022. PMID: 35915082 Free PMC article.

References

1. Zelman S. The liver in obesity. AMA Arch Intern Med 1952;90:141-56. 10.1001/archinte.1952.00240080007002 - DOI - PubMed
1. Clark JM, Diehl AM. Hepatic steatosis and type 2 diabetes mellitus. Curr Diab Rep 2002;2:210-5. 10.1007/s11892-002-0085-3 - DOI - PubMed
1. Itoh S, Tsukada Y, Motomura Y, et al. Five patients with nonalcoholic diabetic cirrhosis. Acta Hepatogastroenterol (Stuttg) 1979;26:90-7. - PubMed
1. Boulet P, Mirouze J, Barjon P, et al. [Non-hemochromatic cirrhosis and diabetes mellitus. (A propos of 25 cases)]. Diabete 1962;10:51-3. - PubMed
1. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84. 10.1002/hep.28431 - DOI - PubMed

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Zelman S. The liver in obesity. AMA Arch Intern Med 1952;90:141-56. 10.1001/archinte.1952.00240080007002 - DOI - PubMed

[2] Zelman S. The liver in obesity. AMA Arch Intern Med 1952;90:141-56. 10.1001/archinte.1952.00240080007002 - DOI - PubMed

[3] Clark JM, Diehl AM. Hepatic steatosis and type 2 diabetes mellitus. Curr Diab Rep 2002;2:210-5. 10.1007/s11892-002-0085-3 - DOI - PubMed

[4] Clark JM, Diehl AM. Hepatic steatosis and type 2 diabetes mellitus. Curr Diab Rep 2002;2:210-5. 10.1007/s11892-002-0085-3 - DOI - PubMed

[5] Itoh S, Tsukada Y, Motomura Y, et al. Five patients with nonalcoholic diabetic cirrhosis. Acta Hepatogastroenterol (Stuttg) 1979;26:90-7. - PubMed

[6] Itoh S, Tsukada Y, Motomura Y, et al. Five patients with nonalcoholic diabetic cirrhosis. Acta Hepatogastroenterol (Stuttg) 1979;26:90-7. - PubMed

[7] Boulet P, Mirouze J, Barjon P, et al. [Non-hemochromatic cirrhosis and diabetes mellitus. (A propos of 25 cases)]. Diabete 1962;10:51-3. - PubMed

[8] Boulet P, Mirouze J, Barjon P, et al. [Non-hemochromatic cirrhosis and diabetes mellitus. (A propos of 25 cases)]. Diabete 1962;10:51-3. - PubMed

[9] Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84. 10.1002/hep.28431 - DOI - PubMed

[10] Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84. 10.1002/hep.28431 - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Nonalcoholic fatty liver disease and type 2 diabetes: a burgeoning problem with unclear solutions

Affiliations

Nonalcoholic fatty liver disease and type 2 diabetes: a burgeoning problem with unclear solutions

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources